This educational review provides an up-to-date overview of severe asthma management, focusing on the heterogeneity of the disease, role of biomarkers, and the latest treatment options, including the novel biologic tezepelumab. It also includes guiding commentary from Clinical Professor John Blakey, Head of the Department of Respiratory Medicine, and Clinical Nurse Consultant Brooke Kyle both based at Sir Charles Gairdner Hospital.
Please login below to download this issue (PDF)